ARQT
Arcutis Biotherapeutics Inc
27.80$
+7.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 99.5% | 98.2% | 98.7% | 97.4% | 96.8% | 96.3% | 95.0% | |
| 89.5% | 77.1% | 59.2% | 21.8% | 24.0% | 11.9% | 25.9% | 20.4% | 9.9% | |
| 89.5% | 99.7% | 94.6% | 95.4% | 95.2% | 91.2% | 79.6% | 65.3% | 51.0% | |
| – | – | 0.1% | 0.2% | 0.1% | 1.9% | 7.6% | 20.9% | 33.8% | |
| – | – | – | -0.2% | 0.3% | 1.7% | 3.8% | 4.2% | 5.2% | |
| – | – | 0.5% | 0.7% | 0.6% | 1.0% | – | – | – | |
| – | – | – | – | – | 1.6% | 1.9% | 2.7% | 3.4% | |
| 230.7% | 146.9% | 5.2% | 9.3% | 27.1% | 53.4% | 74.0% | 54.8% | 56.2% | |
| 18.1% | 5.2% | 4.9% | 7.6% | 8.2% | 8.4% | 13.7% | 23.2% | 30.0% | |
| – | – | 0.2% | – | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | |
| 14.1% | 3.5% | 1.3% | 2.4% | 1.8% | 2.0% | 3.5% | 4.1% | 2.9% | |
| 25.3% | – | – | – | 17.7% | 44.0% | 59.1% | 30.7% | 24.9% | |
| -130.7% | -46.9% | 94.8% | 90.7% | 72.9% | 46.6% | 26.0% | 45.2% | 43.8% | |
| -131.5% | -47.5% | -61.9% | -67.7% | -100.0% | -160.2% | -287.6% | -321.6% | -262.9% | |
| 27.7% | 70.9% | 35.6% | 12.0% | 12.1% | 12.2% | 20.3% | 34.7% | 29.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.